High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

Letter/Communication

Peer reviewed

H. A.F. Stessman, A. Lulla, T. Xia, A. Mitra, T. Harding, A. Mansoor, C. L. Myers, B. G. Van Ness and N. G. Dolloff

Leukemia, Vol.28(11), pp.2263-2267

28

11/01/2014

PMID: 25005244

Abstract

Hematology

Oncology

Cancer Research

4 Record Views

Title: High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma
Creators: H. A.F. Stessman (Author) - University of Minnesota Twin Cities
A. Lulla (Author) - University of Minnesota Twin Cities
T. Xia (Author) - University of Minnesota Twin Cities
A. Mitra (Author) - University of Minnesota Twin Cities
T. Harding (Author) - University of Minnesota Twin Cities
A. Mansoor (Author) - University of Minnesota Twin Cities
C. L. Myers (Author) - University of Minnesota Twin Cities
B. G. Van Ness (Author) - University of Minnesota Twin Cities
N. G. Dolloff (Author) - University of Minnesota Twin Cities
Publication Details: Leukemia, Vol.28(11), pp.2263-2267
Series: 28
Number of pages: 5
Identifiers: 991005929796302656
Academic Unit: Creighton University
Language: English
Resource Type: Letter/Communication